ValueAct Holdings GP, LLC
CIK 1418813 · last filed 2024-12-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MSFT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BUILDING D, 4TH FLOOR
SAN FRANCISCO, CA 94129
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRM | Director | 2,898,509 | $241.23 | $699.21M | -$2.80B | 1 | 2024-12-20 |
| NSIT | Director | 4,511,739 | $178.45 | $805.12M | $290.62M | 5 | 2024-02-20 |
| CBRE | Director | 4,640,103 | $122.14 | $566.74M | -$810.34M | 2 | 2023-08-31 |
| LKQ | Director | 1,102,751 | $17.20 | $18.96M | -$3.55B | 4 | 2023-03-06 |
| FISV | Director | 13,147,776 | $47.28 | $621.63M | $74.78M | 1 | 2022-05-04 |
| AES | Director | 5,346,500 | $15.03 | $80.33M | $48.88M | 1 | 2020-06-15 |
| BHC | Director | 0 | $6.25 | $0 | $0 | 1 | 2020-06-09 |
| Nikola Corp (NKLAW) Delisted | Director | 8,686,587 | — | — | $450.00M | 1 | 2020-06-05 |
| TRN | Director | 25,669,427 | $25.47 | $653.80M | $809.94M | 11 | 2020-02-03 |
| BREAD FINANCIAL HOLDINGS, INC. (ADS) Delisted | Director | 1,378,865 | $56.80 | $78.32M | -$2.97B | 3 | 2019-10-30 |
| UFI | Director | 1,245,902 | $5.56 | $6.93M | $37.58M | 3 | 2019-05-09 |
| ACA | 10%+ Owner | 5,740,963 | $149.15 | $856.26M | -$322.44M | 1 | 2019-03-14 |
| STX | Director | 26,800,163 | $673.71 | $18.06B | $31.25M | 1 | 2018-11-30 |
| AWI | Director | 5,224,910 | $155.85 | $814.30M | -$1.21B | 4 | 2018-09-05 |
| KKR | 10%+ Owner | 48,100,000 | $91.78 | $4.41B | $218.71M | 1 | 2018-02-08 |
| CBRE GROUP, INC. (CBG) Delisted | Director | 27,754,727 | — | — | -$1.15B | 6 | 2017-11-27 |
| FOXA | Director | 53,326,334 | $64.44 | $3.44B | $0 | 2 | 2017-10-03 |
| WILLIS TOWERS WATSON PLC (WLTW) Delisted | Director | 7,709,358 | $231.56 | $1.79B | -$983.72M | 1 | 2017-05-19 |
| ALSN | Director | 11,925,204 | $107.22 | $1.28B | -$1.54B | 3 | 2016-11-21 |
| MSFT | Director | 34,845,281 | $531.04 | $18.50B | -$16.07B | 4 | 2016-07-29 |
| Armstrong Flooring, Inc. (AFI) Delisted | Director | 4,609,071 | $0.35 | $1.62M | $0 | 1 | 2016-04-13 |
| ADBE | Director | 1,012,754 | $249.03 | $252.20M | -$6.77B | 5 | 2016-03-31 |
| MSI | Director | 8,761,437 | $482.25 | $4.23B | -$454.05M | 2 | 2016-03-17 |
| MSCI | Director | 6,272,311 | $602.72 | $3.78B | -$166.58M | 1 | 2016-03-02 |
| OPENLANE, Inc. (KAR) Delisted | Director | 723,628 | $30.88 | $22.35M | -$789.70M | 5 | 2014-08-18 |
| WILLIS TOWERS WATSON PLC (WSH) Delisted | 10%+ Owner | 6,691,129 | — | — | $0 | 1 | 2013-06-10 |
| IT | Director | 1,940,134 | $221.28 | $429.31M | -$45.42M | 5 | 2011-12-08 |
| IMMUCOR INC (BLUD) Delisted | 10%+ Owner | 7,540,665 | — | — | $48.43M | 3 | 2010-07-28 |
| VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | 10%+ Owner | 17,775,603 | — | — | $123.04M | 4 | 2009-07-28 |
| CIM | 10%+ Owner | 285,029 | $8.40 | $2.40M | $15.31M | 3 | 2008-11-17 |
| LiveRamp Holdings, Inc. (ACXM) Delisted | 10%+ Owner | 8,603,457 | — | — | -$66.22M | 2 | 2008-11-12 |
Recent Filings · Page 9 of 10
97 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-07-28 | IMMUCOR INC (BLUD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-07-06 | IT | Grant (A) | — | $0 | EDGAR |
| 2010-05-18 | IMMUCOR INC (BLUD) Delisted | Buy (P) | +458,898 | $9.51M | EDGAR |
| 2010-05-10 | IMMUCOR INC (BLUD) Delisted | Buy (P) | +1,890,000 | $38.92M | EDGAR |
| 2010-04-05 | IT | Grant (A) | — | $0 | EDGAR |
| 2010-01-05 | OPENLANE, Inc. (KAR) Delisted | Buy (P) | +600,000 | $8.23M | EDGAR |
| 2009-07-28 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +236,400 | $5.89M | EDGAR |
| 2009-06-11 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +1,008,510 | $22.91M | EDGAR |
| 2009-06-03 | — | Other (J) | −19,747,956 | -$78.99M | |
| 2009-05-19 | VALEANT PHARMACEUTICALS INTERNATIONAL (VRX) Delisted | Buy (P) | +281,320 | $5.58M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.